Literature DB >> 12417663

Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons.

Masako M Bilak1, S Patricia Becerra, Andrea M Vincent, Brian H Moss, Maria S Aymerich, Ralph W Kuncl.   

Abstract

Pigment epithelium-derived factor (PEDF), a member of the serine protease inhibitor (serpin) family, is a survival factor for various types of neurons. We studied the mechanisms by which human PEDF protects motor neurons from degeneration, with the goal of eventually conducting human clinical trials. We first searched for a molecular region of human PEDF essential to motor neuron protection. Using a spinal cord culture model of chronic glutamate toxicity, we show herein that a synthetic 44 mer peptide from an N-terminal region of the human PEDF molecule that lacks the homologous serpin-reactive region contains its full neuroprotective activity. We also investigated the presence and distribution of PEDF receptors in the spinal cord. Using a fluoresceinated PEDF probe, we show that spinal motor neurons contain specific binding sites for PEDF. Kinetics analyses using a radiolabeled PEDF probe demonstrate that purified rat motor neurons contain a single class of saturable and specific binding sites. This study indicates that a small peptide fragment of the human PEDF molecule could be engineered to contain all of its motor neuron protective activity, and that the neuroprotective action is likely to be mediated directly on motor neurons via a single class of PEDF receptors. The data support the pharmacotherapeutic potential of PEDF as a neuroprotectant in human motor neuron degeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417663      PMCID: PMC6758058     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Similarity and difference in the effects of peptides TGENHR and TQVEHR on HL-60 promyelocytes and Purkinje cells of rat cerebellar vermis.

Authors:  S S Zhokhov; I A Kostanyan; N V Gibanova; E A Surina; Z I Storozheva; I I Babichenko; V M Lipkin
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb

2.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

3.  Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.

Authors:  Omar Ladhani; Cristina Sánchez-Martinez; Jose L Orgaz; Benilde Jimenez; Olga V Volpert
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

4.  PEDF-derived peptide promotes skeletal muscle regeneration through its mitogenic effect on muscle progenitor cells.

Authors:  Tsung-Chuan Ho; Yi-Pin Chiang; Chih-Kuang Chuang; Show-Li Chen; Jui-Wen Hsieh; Yu-Wen Lan; Yeou-Ping Tsao
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-03       Impact factor: 4.249

5.  Pigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction.

Authors:  Shu-Wei Tian; Yuan Ren; Jin-Zhi Pei; Bai-Chao Ren; Yuan He
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

6.  The PEDF Neuroprotective Domain Plus DHA Induces Corneal Nerve Regeneration After Experimental Surgery.

Authors:  Jiucheng He; M Soledad Cortina; Azucena Kakazu; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

Review 7.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

Review 8.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

9.  Codon preference optimization increases heterologous PEDF expression.

Authors:  Anzor G Gvritishvili; Kar Wah Leung; Joyce Tombran-Tink
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 10.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.